Borusan Yat. Paz.
1911.00
12-March-25 08:26:19
15 minutes delayed
Stocks
-4.00
-0.21%
Today's range
1903.00 - 1940.00
ISIN
TRABRYAT91Q2
Source
Borsa Istanbul
-
Citigroup Upgrades Unity Software (NYSE:U) to Buy
12 Mar 2025 07:41:16 By Buzz FX
-
Stephens Reaffirms "Overweight" Rating for First Watch Restaurant Group (NASDAQ:FWRG)
12 Mar 2025 07:41:16 By Buzz FX
-
GE HealthCare Technologies (NASDAQ:GEHC) Upgraded by The Goldman Sachs Group to "Buy" Rating
12 Mar 2025 07:41:16 By Buzz FX
-
William Blair Upgrades Genmab A/S (NASDAQ:GMAB) to Outperform
12 Mar 2025 07:41:16 By Buzz FX
-
Lumentum (NASDAQ:LITE) Upgraded by BNP Paribas to Outperform Rating
12 Mar 2025 07:41:16 By Buzz FX
-
UniCredit Needs Antitrust Approval to Convert Commerzbank Stake
12 Mar 2025 07:36:28 By Buzz FX
-
Ulta Beauty's (ULTA) "Outperform" Rating Reaffirmed at Telsey Advisory Group
12 Mar 2025 07:36:16 By Buzz FX
-
Gilead Sciences (NASDAQ:GILD) Given New $130.00 Price Target at Morgan Stanley
12 Mar 2025 07:36:16 By Buzz FX
-
enGene (NASDAQ:ENGN) Given "Buy" Rating at HC Wainwright
12 Mar 2025 07:36:16 By Buzz FX
-
Bicycle Therapeutics (NASDAQ:BCYC) Receives Buy Rating from Needham & Company LLC
12 Mar 2025 07:36:16 By Buzz FX
-
Rosenblatt Securities Reiterates "Buy" Rating for Canaan (NASDAQ:CAN)
12 Mar 2025 07:36:16 By Buzz FX
-
Barrington Research Reaffirms "Outperform" Rating for Distribution Solutions Group (NASDAQ:DSGR)
12 Mar 2025 07:36:16 By Buzz FX
-
WM Technology's (MAPS) "Buy" Rating Reiterated at Westpark Capital
12 Mar 2025 07:36:16 By Buzz FX
-
ONE Group Hospitality's (STKS) "Neutral" Rating Reiterated at Wedbush
12 Mar 2025 07:36:16 By Buzz FX
-
HC Wainwright Reiterates Buy Rating for Fennec Pharmaceuticals (NASDAQ:FENC)
12 Mar 2025 07:36:16 By Buzz FX
-
Asana (NYSE:ASAN) Price Target Cut to $13.00 by Analysts at Robert W. Baird
12 Mar 2025 07:36:16 By Buzz FX
-
Asana (NYSE:ASAN) Price Target Lowered to $25.00 at Bank of America
12 Mar 2025 07:36:16 By Buzz FX
-
Inozyme Pharma (NASDAQ:INZY) Price Target Cut to $15.00 by Analysts at Needham & Company LLC
12 Mar 2025 07:36:16 By Buzz FX
-
Checkpoint Therapeutics (NASDAQ:CKPT) Given "Neutral" Rating at HC Wainwright
12 Mar 2025 07:36:16 By Buzz FX
-
Coherus BioSciences (NASDAQ:CHRS) Receives "Buy" Rating from HC Wainwright
12 Mar 2025 07:36:16 By Buzz FX